Tredje AP fonden Has $2.27 Million Stake in Cardinal Health, Inc. (NYSE:CAH)

Tredje AP fonden cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,200 shares of the company's stock after selling 19,199 shares during the quarter. Tredje AP fonden's holdings in Cardinal Health were worth $2,271,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Frazier Financial Advisors LLC lifted its holdings in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after buying an additional 104 shares during the last quarter. Promus Capital LLC bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $30,000. AM Squared Ltd bought a new stake in shares of Cardinal Health during the third quarter valued at approximately $33,000. Kentucky Trust Co bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $41,000. Finally, HHM Wealth Advisors LLC increased its position in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after purchasing an additional 144 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of CAH stock traded up $1.33 during trading hours on Tuesday, hitting $131.36. 1,529,472 shares of the company's stock were exchanged, compared to its average volume of 1,976,591. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The stock has a market cap of $31.73 billion, a price-to-earnings ratio of 24.51, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The stock's 50-day moving average is $126.54 and its 200-day moving average is $119.56.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CAH. Wells Fargo & Company boosted their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Citigroup boosted their price objective on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Morgan Stanley upped their price target on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.